SYNTHESIS OF 1-[ω-(BROMOPHENOXY)ALKYL]-3-NAPHTHALENYLMETHYL DERIVATIVES OF URACIL AND THEIR ANALOGUES AS PROBABLE INHIBITORS OF HUMAN CYTOMEGALOVIRUS REPLICATION

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

A new series of 1-[ω-(bromophenoxy) has been synthesizedalkyl]-uracil derivatives containing naphthalene-1-yl-, naphthalene-2-yl-, 1-brominaphthalene-2-ilmethyl, benzyl and anthracene-9-ilmethyl fragments in position 3 of uracil. Antiviral properties of synthesized compounds against human cytomegalovirus were studied. It was found that the compound, which has a bridge consisting of five methylene groups, has high anti-cytomegalovirus activity in vitro. uracil

About the authors

M. P. Paramonova

Volgograd State Medical University

Email: khandazhinskaya@bk.ru
Russian Federation, Volgograd

E. S. Gureeva

Volgograd State Medical University

Email: khandazhinskaya@bk.ru
Russian Federation, Volgograd

A. A. Ozerova

Volgograd State Medical University

Email: khandazhinskaya@bk.ru
Russian Federation, Volgograd

R. Snoeck

Rega Institute for Medical Research, KU Leuven

Email: khandazhinskaya@bk.ru
Belgium, B-3000, Leuven, Herestraat 49 bus 1043

G. Andrei

Rega Institute for Medical Research, KU Leuven

Email: khandazhinskaya@bk.ru
Belgium, B-3000, Leuven, Herestraat 49 bus 1043

D. A. Alexandrov

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences

Email: khandazhinskaya@bk.ru
Russian Federation, Moscow

A. L. Khandazhinskaya

V.A. Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences

Author for correspondence.
Email: khandazhinskaya@bk.ru
Russian Federation, Moscow

M. S. Novikova

Volgograd State Medical University

Email: khandazhinskaya@bk.ru
Russian Federation, Volgograd

S. N. Kochetkov

V.A. Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences

Email: khandazhinskaya@bk.ru
Russian Federation, Moscow

References

  1. Rodríguez-Goncer I., Fernández-Ruiz M., Aguado J.M. // Expert Rev. Anti. Infect. Ther. 2020. V. 18. P. 113–125.
  2. Karrer U., Mekker A., Wanke K., Tchang V., Haeberli L. // Exp. Gerontol. 2009. V. 44. P. 689–694.
  3. Jentzer A., Veyrard P., Roblin X., Saint-Sardos P., Rochereau N., Paul S., Bourlet T., Pozzetto B., Pillet S. // Microorganisms. 2020. V. 8. P. 1078.
  4. Richardson A.K., Walker L.C., Cox B., Rollag H., Ro-binson B.A., Morrin H., Pearson J.F., Potter J.D., Pater-son M., Surcel H.M., Pukkala E., Currie M.J. // Clin. Transl. Oncol. 2020. V. 22. P. 585–602.
  5. Lv Y.L., Han F.F., An Z.L., Jia Y., Xuan L.L., Gong L.L., Zhang W., Ren L.L., Yang S., Liu H., Liu L.H. // Intervirology. 2020. V. 63. P. 10–16.
  6. Plotkin S.A., Boppana S.B. // Vaccine. 2019. V. 37. P. 7437–7442.
  7. Permar S.R., Schleiss M.R., Plotkin S.A. // J. Virol. 2018. V. 92. P. e00030–18.
  8. Kotton C.N. // Curr Opin Organ Transplant. 2019. V. 24. P. 469–475.
  9. Sellar R.S., Peggs K.S. // Expert Opin. Biol. Ther. 2012. V. 12. P. 1161–1172.
  10. Faure E., Galperine T., Cannesson O., Alain S., Gnemmi V., Goeminne C., Dewilde A., Béné J., Lasri M., Lessore de Sainte Foy C., Lionet A. // Medicine. 2016. V. 95. P. e5226.
  11. Tan B.H. // Options Infect. Dis. 2014. V. 6. P. 256–270.
  12. El Helou G., Razonable R.R. // Infect. Drug Resist. 2019. V. 12. P. 1481–1491.
  13. Papanicolaou G.A., Silveira F.P., Langston A.A., Perei-ra M.R., Avery R.K., Uknis M., Wijatyk A., Wu J., Boeckh M., Marty F.M., Villano S. // Clin. Infect. Dis. 2019. V. 68. P. 1255–1264.
  14. Piret J., Boivin G. // Antiviral Res. 2019. V. 163. P. 91–105.
  15. Novikov M.S., Babkov D.A., Paramonova M.P., Khandazhinskaya A.L., Ozerov A.A., Chizhov A.O., Andrei G., Snoeck R., Balzarini J., Seley-Radtke K.L. // Bioorg. Med. Chem. 2013. V. 21. P. 4151–4157.
  16. Babkov D.A., Khandazhinskaya A.L., Chizhov A.O., Andrei G., Snoeck R., Seley-Radtke K.L., Novikov M.S. // Bioorg. Med. Chem. 2015. V. 23. P. 7035–7044.
  17. Maruyama T., Kozai S., Yamasaki T., Witvrouw M., Pannecouque C., Balzarini J., Snoeck R., Andrei G., De Clercq E. // Antivir. Chem. Chemother. 2003. V. 14. P. 271–279.
  18. Maruyama T., Demizu Y., Kozai S., Witvrouw M., Pannecouque C., Balzarini J., Snoecks R., Andrei G., De Clercq E. // Nucleosides Nucleotides Nucleic Acids. 2007. V. 26. P. 1553–1558.
  19. Novikov M.S., Valuev-Elliston V.T., Babkov D.A., Paramonova M.P., Ivanov A.V., Gavryushov S.A., Khandazhinskaya A.L., Kochetkov S.N., Pannecouque C., Andrei G., Snoeck R., Balzarini J., Seley-Radtke K.L. // Bioorg. Med. Chem. 2013. V. 21. P. 1150–1158.
  20. Paramonova M.P., Khandazhinskaya A.L., Ozerov A.A., Kochetkov S.N., Snoeck R., Andrei G., Novikov M.S. // Acta Naturae. 2020. V. 12. P. 134–139.
  21. Paramonova M.P., Snoeck R., Andrei G., Khandazhinskaya A.L., Novikov M.S. // Mendeleev Commun. 2020. V. 30. P. 602–603.
  22. Baker B.R., Kelley J.L. // J. Med. Chem. 1970. V. 13. P. 458–461.

Supplementary files

Supplementary Files
Action
1. JATS XML
2.

Download (73KB)
3.

Download (46KB)
4.

Download (47KB)
5.

Download (42KB)

Copyright (c) 2023 М.П. Парамонова, Е.С. Гуреева, А.А. Озеров, R. Snoeck, G. Andrei, Д.А. Александров, А.Л. Хандажинская, М.С. Новиков, С.Н. Кочетков

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies